login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
RENOVORX INC (RNXT) Stock News
USA
- NASDAQ:RNXT -
US75989R1077
-
Common Stock
1.11
USD
+0.1 (+9.36%)
Last: 10/31/2025, 8:12:13 PM
1.1
USD
-0.01 (-0.9%)
Pre-Market:
11/3/2025, 9:05:18 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RNXT Latest News, Press Relases and Analysis
All
Press Releases
25 days ago - By: RenovoRx, Inc.
RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD
a month ago - By: RenovoRx, Inc.
RenovoRx’s PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites
6 months ago - By: Benzinga
Earnings Preview For RenovoRx
2 months ago - By: ACCESS Newswire
- Mentions:
NNBR
XTRA.CA
HIT
CJMB
...
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025
2 months ago - By: RenovoRx, Inc.
RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th
2 months ago - By: ACCESS Newswire
- Mentions:
NNBR
XTRA.CA
HIT
OESX
...
iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025
2 months ago - By: Benzinga
- Mentions:
IFRX
ALEC
TNYA
Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge
3 months ago - By: RenovoRx, Inc.
RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 27th Annual Global Investment Conference in New York City, September 8-10, 2025
3 months ago - By: The Motley Fool
RenovoRx Revenue Jumps 28 Percent in Q2
3 months ago - By: Zacks Investment Research
- Mentions:
HQY
RenovoRx, Inc. (RNXT) Reports Q2 Loss, Tops Revenue Estimates
3 months ago - By: RenovoRx, Inc.
RenovoRx Reports Commercial Revenue Growth in the Second Quarter 2025 and Announces Positive Independent Data Monitoring Committee Recommendation to Continue Pivotal Phase III TIGeR-PaC Trial Based on Interim Data Review
3 months ago - By: RenovoRx, Inc.
RenovoRx Expands U.S. Commercialization Efforts for the RenovoCath® Device with Growing Customer Demand and Key Leadership Hire
3 months ago - By: RenovoRx, Inc.
RenovoRx Launches Multi-Center Post-Marketing Registry Study to Evaluate Cancer Treatment Delivered by RenovoCath® Device to Solid Tumors
4 months ago - By: RenovoRx, Inc.
RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call on August 14th at 4:30 p.m. ET
5 months ago - By: Yahoo Finance
- Mentions:
BBY
HSCS
KSCP
BKNG
...
RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results
5 months ago - By: Yahoo Finance
- Mentions:
OMI
SMLR
RDY
HUM
...
Owens & Minor and Rotech Healthcare Agree to End Previously Planned Acquisition
5 months ago - By: Yahoo Finance
- Mentions:
SO
OMI
EPD
PWR
...
PowerSecure Partners with Edged to Advance Eco-Friendly Data Centers Across the Country
6 months ago - By: Zacks Investment Research
- Mentions:
AUNA
RenovoRx, Inc. (RNXT) Reports Q1 Loss, Lags Revenue Estimates
6 months ago - By: RenovoRx, Inc.
RenovoRx Reports First Quarter 2025 Financial Results and Business Highlights
6 months ago - By: RenovoRx, Inc.
RenovoRx to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21st
6 months ago - By: RenovoRx, Inc.
U.S. Patent Office Issues New Patent to RenovoRx for Novel Trans-Arterial Micro-Profusion (TAMP™) Therapy Platform
6 months ago - By: RenovoRx, Inc.
RenovoRx to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET
6 months ago - By: RenovoRx, Inc.
Johns Hopkins Medicine Initiates Patient Enrollment for RenovoRx’s Ongoing Phase III TIGeR-PaC Clinical Trial
7 months ago - By: RenovoRx, Inc.
RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community
7 months ago - By: RenovoRx, Inc.
RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th
7 months ago - By: RenovoRx, Inc.
RenovoRx Reports Initial Revenues from RenovoCath® Commercialization, and Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
Please enable JavaScript to continue using this application.